Literature DB >> 8277177

Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.

M van Deuren1, J van der Ven-Jongekrijg, P N Demacker, A K Bartelink, R van Dalen, R W Sauerwein, H Gallati, J L Vannice, J W van der Meer.   

Abstract

Circulating concentrations of tumor necrosis factor-alpha (TNF), interleukin (IL)-1 beta, IL-6, IL-1 receptor antagonist (IL-1ra), and soluble TNF receptors p55 (sTNFr-55) and p75 (sTNFr-75) and ex vivo production of TNF, IL-1, IL-6, and IL-1ra using a whole blood culture system were measured during the acute and convalescent stages of meningococcal infection. Circulating TNF and IL-1 were below detection level, whereas IL-6 and IL-1ra, sTNFr-55, and sTNFr-75 were increased at admission. The ex vivo production of proinflammatory cytokines TNF, IL-1, and IL-6 was suppressed at admission and restored gradually during recovery. On the contrary, the production of the antiinflammatory IL-1ra was increased at admission. The elevated concentrations of both IL-1ra and sTNFr early in the course of infection suggest a regulatory role for these antiinflammatory compounds. The observed down-regulation of the ex vivo production of TNF, IL-1, and IL-6 and up-regulation of the production of IL-1ra in the acute stage may indicate a protective regulation mechanism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8277177     DOI: 10.1093/infdis/169.1.157

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.

Authors:  Anna Simon; Heiyoung Park; Ravikanth Maddipati; Adrian A Lobito; Ariel C Bulua; Adrianna J Jackson; Jae Jin Chae; Rachel Ettinger; Heleen D de Koning; Anthony C Cruz; Daniel L Kastner; Hirsh Komarow; Richard M Siegel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Minimally invasive surgery induces endotoxin-tolerance in the absence of detectable endotoxemia.

Authors:  L C Lemaire; T van der Poll; J J van Lanschot; E Endert; W A Buurman; S J van Deventer; D J Gouma
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

Review 3.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.

Authors:  C A Evans; J Jellis; S P Hughes; D G Remick; J S Friedland
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

5.  A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis.

Authors:  Enitan D Carrol; Alistair P J Thomson; Ashley P Jones; Graham Jeffers; C Anthony Hart
Journal:  Intensive Care Med       Date:  2005-08-27       Impact factor: 17.440

6.  Soluble tumour necrosis factor (TNF)-receptor levels in serum as markers of anti-viral host reactivity.

Authors:  C Bartholdy; A Nansen; O Marker; A R Thomsen
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

7.  Murine responses to endotoxin: another dirty little secret?

Authors:  Robert S Munford
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

8.  Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease.

Authors:  Chandy C John; Gregory S Park; Nadia Sam-Agudu; Robert O Opoka; Michael J Boivin
Journal:  Cytokine       Date:  2008-02-20       Impact factor: 3.861

9.  Severity of meningococcal infections is related to anthropometrical parameters.

Authors:  N Perez; L Regairaz; J Bustamante; N Osimani; D Bergna; J Morales; M R Agosti; S Gonzalez-Ayala; C Peltzer; A Rodrigo
Journal:  Arch Dis Child       Date:  2007-05-08       Impact factor: 3.791

Review 10.  Monitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.

Authors:  Guillaume Monneret; Fabienne Venet; Alexandre Pachot; Alain Lepape
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.